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Abstract 
Several peptidic and non-peptidic factors can modulate Na,K-ATPase activity, among them mainly inhibitors of this enzyme, ouabain being the 
most effective. In a very few cases only, activation of Na,K-ATPase by endogenous factors has heen recorded. We have investigated the effect on 
Na,K-ATPase of a novel regulatory peptide, PEC-60, recently isolated from porcine intestine. Various biological effects have been described for 
PEC-60 in different tissues, including brain. We have found that PEC-60 caused a dose-dependent activation of Na,K-ATPase from rat brain frontal 
cortex, whereas the carboxymethylated form of PEC-60 or other hormonal peptides had no effect. The maximal value of activity reaches up to 125% 
at close to micromolar concentrations of PEG60 and the dependence can be described with a bell-shaped curve, indicating a complex mechanism 
for the interaction. The activation of the enzyme by PEG60 is apparently related to Na+-dependent steps of the Na,K-ATPase system. The kinetic 
parameters for K+-phosphatase were unaffected. Moreover, the activating effect was enhanced by preincubation at low concentrations of ATP that 
transform the enzyme into the Na’-form. Due to the crucial physiological role of Na,K-ATPase, its activity has to be finely controlled and thus PEG60 
may be one of the endogenous factors that regulate this enzyme. 
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1. Introduction 
Since Na,K-AVase regulates several essential cellular 
functions, such as intracellular homeostasis of Na+ and 
K’ ions, pH, membrane potential, cell volume, cellular 
uptake of amino acids and sugars in different tissues, the 
activity of this enzyme has to be finely controlled [l]. 
Numerous peptidic and non-peptidic factors have been 
found to influence Na,K-ATPase activity [2-61. The reg- 
ulators of Na,K-ATPase can be divided into two large 
groups: (i) direct modulators of activity (ouabain, ATP, 
Na+, K’, some peptides) and (ii) indirect modulators, 
which include several peptide and non-peptide hormones 
and neurotransmitters (for review see [2,3]). While the 
direct modulators bind to the enzyme protein, the effects 
of the latter group of compounds are mediated via bind- 
ing to membranes or specific receptors. However, the 
majority of the known modulators are inhibitors of 
Na,K-ATPase. 
Several research groups have recently reported the pu- 
rification of non-peptidic endogenous Na,K-ATPase in- 
hibitors to high purity [7,8]; however, the exact structures 
and actual functions of these have not yet been deter- 
mined. Recently the structures of three peptidic inhib- 
itors (SPAI-1, -2, -3) have been disclosed [9]. Structur- 
ally, these peptides belong to a protein group together 
with human mucous protease inhibitor [lo] and with 
human elastase-specific inhibitor elafin [ll]. The latter 
*Corresponding author. Fax: (49) (511) 546 6102. 
two members of this group are protease inhibitors, while 
such features have not been found for the SPAIs. 
The endogenous activators of Na,K-ATPase have re- 
ceived much less attention. Only in a few cases has acti- 
vation of Na,K-ATPase by some regulators been de- 
scribed. Insulin [12-141, thyroxine [15], glucagon [14], 
bradykinin [16] and the N-terminal fragment of sub- 
stance P (SPl-5) [17] have been found to activate Na,K- 
ATPase. Activation of the enzyme by these modulators 
may occur by different, most likely receptor-mediated, 
mechanisms. 
Recently a 60-residue polypeptide, denoted PEC-60, 
was isolated from porcine intestinal tissue [18]. Accord- 
ing to its structure, this peptide belongs to a group of 
peptidic protease inhibitors (PSTIs), although no sub- 
stantial anti-protease activity has been demonstrated for 
it [ 181. Significantly, various other biological effects have 
been described for PEC-60 in brain tissue [19,20]. How- 
ever, the mechanisms for these effects are not yet under- 
stood. 
In this report we demonstrate that PEG60 modulates 
rat brain Na,K-ATPase activity, as do some other, al- 
though structurally unrelated, anti-protease-like pep- 
tides (SPAIs) [9]. The results show, however, that, in 
contrast to the SPAIs, PEG60 has a rather significant 
stimulatory effect on the activity of this enzyme. 
2. Materials and methods 
2.1. Materials 
PEC-60 was purified from porcine intestine essentially as described 
[18] and was analyzed by amino acid composition analysis, mass spec- 
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trometry and sequencing. Other chemicals used were from Sigma or 
Merck. 
2.2. Carboxymethylation of PEC-40 
5 mg of PEG60 was reduced with 0.5 M dithiothreitol for 2 h at 
37°C. A large excess of 100 mM iodoacetic acid was added and the 
reaction continued for another 2 h at the same temperature. The deri- 
vatixed peptide was purified by reverse-phase HPLC. The carbox- 
ymethylated peptide had a molecular mass of 7190.9 f 1.1 Da com- 
pared to the theoretical value of 7190.8 Da. 
2.3. Na,K-ATPase preparations and assays 
Na,K-ATPase was prepared from brain frontal cortex of adult rats 
(Wistar, 250-300 g) by a method described earlier [21]. Na,K-ATPase 
activity was measured as follows. Membrane protein (10-20 pg) was 
incubated in 375 ~1 of incubation medium containing 100 mM NaCl, 
20 mM KCl, 4 mM MgCl*, 4 mM Tris-ATP and 25 mM imidaxole-HCl 
@H 7.4) at 37’C. This mixture was preincubated for 5 mm at 37’C and 
the reaction was started by the addition of the enzyme preparation. The 
reaction was terminated after 5 min by the addition of cold 3% SDS, 
and inorganic phosphate Pi was determined as described earlier [21]. 
Na,K-ATPase activity was determined as the difference between the 
release of Pi from ATP in the absence and presence of 1 mM ouabain 
or in the absence and presence of NaCl and KC1 in the incubation 
medium. Na,K-ATPase specific activity in the preparation was 54-72 
pmol P..mg protein-‘.h-‘. The protein content was determined by the 
method of Lowry [22] using bovine serum albumin as a standard. The 
activity of Na,K-ATPase was linear as a function of incubation time 
and the amount of enzyme under the experimental conditions. 
2.4. Assay for K+-phosphatase 
K+-phosphatase was assayed as described earlier [21]. Briefly, mem- 
brane protein (30-50 jfg) was incubated in 750~1 of medium containing 
4 mM MgCl,, 3 mMpnitropheny1 phosphate, 10 mM KC1 and 50 mM 
Tris-HCl @H 7.7) at 37 “C. Preincubation time was 5 mm at 37°C and 
the reaction was started by the addition of the enzyme preparation, and 
the reaction was terminated after 15 min by the addition of 0.025 M 
NaOH, containing 0.025% EDTA. The content of p-nitrophenol was 
determined at 400 mn in the absence and presence of KC1 and the 
specific activity of K+-phosphatase was expressed as ~01 p-nitrophe- 
nobmg proteir+min-‘. 
3. Resuhs and discussion 
To examine whether PEG60 can intiuence the activity 
of Na,K-ATPase a time-course study was carried out. 
The activation effect of PEG60 was independent of time 
within 30 min of preincubation (Fig. 1). The activation 
of Na,K-ATPase by PEC-60 was concentration-depend- 
ent and can be described by a bell-shaped curve with a 
peak value close to micromolar concentrations of the 
peptide (Fig. 2). The maximum value of the enzyme ac- 
tivity reaches approximately 125%. The activity of Mg- 
ATPase was unatTected (data not shown). 
To investigate whether the activation is specific for the 
native conformation of PEC-60 we reduced the three 
disulfide bridges in the peptide and carboxymethylated 
the cysteines. Neither inhibition nor activation was ob- 
served with the carboxymethylated peptide (Fig. 2). 
Other hormonal peptides, such as galanin at OS-50 PM 
(data not shown) also failed to modulate the enzyme 
activity. These data indicate that Na,K-ATPase activa- 
tion is specific for PEG60 and is dependent on its native 
conformation. 
We found that the action of PEG60 was even en- 
hanced by preincubation at low concentrations (0.15 
mM) of ATP to a certain extent, reaching up to 134% 
under such conditions. It is known that low concentra- 
tions of ATP transform Na,K-ATPase into the Na’- 
form [l]. Therefore we suspected that the influence of 
PEG60 might be related to Na’-dependent reaction 
steps catalyzed by Na,K-ATPase. To verify this hypoth- 
esis we investigated the effects of PEG60 and its carbox- 
ymethylated form on K’-phosphatase, which is the K’- 
dependent step of the Na,K-ATPase reaction. Native 
PEG60 or carboxymethylated PEC-60 did not have any 
effects on the activity of K’-phosphatase (Fig. 3). The 
kinetic parameters for the K’-ion were nH = 1.6 + 0.1 
and Ko.5 = 4.4 f 0.8 at 3 ,uM PEC-60, and for the control 
experiment without the peptide nH = 1.6 f 0.1 and 
K& = 4.8 rts 0.9. Similar results were also obtained with 
1 ,uM and 80 ,uM concentrations of native PECBO, and 
with 1 PM of carboxymethylated PEG60 (data not 
shown). From this we could conclude that the activation 
is not associated with the steps related to K’-phosphat- 
ase. 
On the other hand, the affinities for Na’+ were also 
rather similar in the absence (k& = 10.3 f 1.8 mM) and 
presence (& = 11.7 + 2.8 mM) of PEC-60. However, 
the degree of cooperativity for Na’ in the Na,K-ATPase 
reaction was slightly altered after preincubation of the 
enzyme preparations with PEG60. The Hill coefficients 
were nH = 1.6 f 0.1 and nH = 1.3 + 0.1 in the absence 
and presence of PEC-60, respectively. Moreover, when 
we measured the enzyme activity in the absence of K’ 
after preincubation of the enzyme preparation with PEC- 
60, the maximal activity was 114 + 3% at 100 mM Na+, 
119 + 4% at 33 mM Na+, and 108 f 2% at 14 mM Na+, 
1 
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Fig. 1. Timecourse of activation of rat brain Na,K-ATPase by PEC- 
60. The membranes were incubated with 1 ,uM PEG60 in reaction 
buffer for indicated times and Na,K-ATPase assayed as described in 
section 2. Values are given as mean k S.E.M. of 4-6 measurements. 
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thus indicating a slight dependence on Na+ concentra- 
tion in the reaction mixture. 
It has been shown earlier that the effects of some other 
structurally protease inhibitor-like peptides, such as 
SPAIs, on the activity of Na,K-ATPase are also Na’- 
related, acting competitively against Na’ and being un- 
competitive with K’ [9]. In contrast to the inhibitory 
effects of SPAIs [23], PEC-60 has an activating influence 
on Na,K-ATPase from rat brain frontal cortex. It is 
obvious that the interactions of PEC-60, as well as 
SPAIs, with Na,K-ATPases are relatively complex. It is 
likely that the bell-shaped influence curve refers to the 
possibility that PEG60 binds to at least two binding sites 
on the enzyme with different amnities. At low concentra- 
tions PEG60 acts as an activator of the enzyme and at 
higher concentrations the activating effect is reversed by 
binding another molecule of PEG60. It should be men- 
tioned that also in the case of SPAI- the modulatory 
effect is described by a similar bell-shaped curve for 
Na,K-ATPase from some organs like heart and intestine 
[23]. For the enzyme from intestine a 20% activation by 
SPAI- can be observed at submicromolar concentra- 
tions [23] leading to inhibition at higher peptide concen- 
trations. Such behavior may indicate similar actions of 
SPAI- and PEC-60. 
We have also studied the effect of PEC-60 on the 
Na’/H’-exchanger using cultured fibroblasts (to be pub- 
lished elsewhere), where the influence of PEG60 seems 
to be Na+-related as well. It has been suggested earlier 
that the export of protons from cells is based on the 
cooperation between Na,K-ATPase and the Na’/H+-ex- 
changer [24]. Although we do not yet know the exact 
effect of PEG60 on Na,K-ATPase isoforms from intesti- 
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Fig. 2. Dose-response influence of PEC-60 on rat brain Na,K-ATPase 
activity. The membranes (35 ,ug protein/ml) were preincubated with 
indicated concentrations of PEC-60 (o), carboxymethylated PEC-60 
(0) for 25 min at 25°C and Na,K-ATPase assayed as described in 
section 2. Values indicate mean f S.E.M. of 47 measurements. 
-1.5! . I . I . , . , . I 
0 0.2 0.4 0.6 0.8 1.0 
WK+l 
Fig. 3. Hill plot showing the lack of effect of PEC-60 on the cooperativ- 
ity for K+ with K’-phosphatase. The enzyme preparation was preincu- 
bated at 25’C in the absence (0) or presence (0) of 3 PM PEC-60 for 
25 min and K+-phosphatase was assayed as described in section 2. The 
result of a typical experiment out of 4 is shown. 
nal tissue, where PEC-60 is abundant, these data lead us 
to speculate that, via simultaneous intIuence of PEG60 
on Na,K-ATPase and the Na+/H+-exchanger, PEG60 
might participate in the fine regulation of proton and 
Na+,K+-ion homeostasis in cells. The data obtained in 
this study could possibly help to explain some of the 
bioactivities described earlier for this peptide. Especially 
in view of PEC-60 having been discovered by way of its 
inhibitory activity on the release of insulin, it is of inter- 
est that inhibition of insulin release from rat pancreatic 
islets has been shown to be accompanied by activation 
of islet Na,K-ATPase [25]. 
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